Patrick M. Schlievert
Impact in
- Infectious Diseases top 0.01%
- Antimicrobial Resistance in Staphylococcus
- Clostridium difficile and Clostridium perfringens research
- Clinical Biochemistry top 0.05%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antimicrobial Resistance in Staphylococcus 203
- Clostridium difficile and Clostridium perfringens research 38
- Immunology 175
- Toxin Mechanisms and Immunotoxins 103
- Immune Response and Inflammation 59
- Co-authors
- Paul M. Orwin (6 shared papers)Martin M. Dinges (8 shared papers)Jeremy M. Yarwood (10 shared papers)Richard P. Novick (25 shared papers)Barry N. Kreiswirth (20 shared papers)John K. McCormick (25 shared papers)Donald Y.M. Leung (43 shared papers)Gregory A. Bohach (32 shared papers)
- Journals
- Infection and Immunity (54 papers)The Journal of Infectious Diseases (29 papers)Clinical Infectious Diseases (19 papers)PLoS ONE (17 papers)Biochemistry (15 papers)
- Partner nations
- United StatesCanadaRussia
In The Last Decade
Patrick M. Schlievert
392 papers receiving 27.4k citations
Patrick M. Schlievert's Hit Papers
Peers
Comparison fields: 5 of 161
- Infectious Diseases 16.0k
- Clinical Biochemistry 2.8k
- Microbiology 2.4k
- Immunology 6.9k
- Public Health, Environmental and Occupational Health 8.6k
Countries citing papers authored by Patrick M. Schlievert
This map shows the geographic impact of Patrick M. Schlievert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick M. Schlievert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick M. Schlievert more than expected).
Fields of papers citing papers by Patrick M. Schlievert
This network shows the impact of papers produced by Patrick M. Schlievert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick M. Schlievert. The network helps show where Patrick M. Schlievert may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick M. Schlievert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 406 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Exotoxins of Staphylococcus aureus Hit paper breakdown → | 2000 | 1325 |
| 2 | The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage Hit paper breakdown → | 1983 | 1189 |
| 3 | Severe Group A Streptococcal Infections Associated with a Toxic Shock-like Syndrome and Scarlet Fever Toxin A Hit paper breakdown → | 1989 | 1009 |
| 4 | Exotoxins ofStaphylococcus aureus Hit paper breakdown → | 2000 | 825 |
| 5 | Toxic Shock Syndrome and Bacterial Superantigens: An Update Hit paper breakdown → | 2001 | 617 |
| 6 | Identification and Characterization of an Exotoxin from Staphylococcus aureus Associated with Toxic-Shock Syndrome Hit paper breakdown → | 1981 | 583 |
| 7 | Regulation of exoprotein gene expression in Staphylococcus aureus by agr Hit paper breakdown → | 1986 | 541 |
| 8 | Glycerol monolaurate prevents mucosal SIV transmission Hit paper breakdown → | 2009 | 519 |
| 9 | 1988 | 497 | |
| 10 | Clinical and Bacteriologic Observations of a Toxic Shock–like Syndrome Due toStreptococcus pyogenes Hit paper breakdown → | 1987 | 477 |
| 11 | 2002 | 421 | |
| 12 | 1990 | 419 | |
| 13 | Staphylococcal and Streptococcal Superantigen Exotoxins Hit paper breakdown → | 2013 | 397 |
| 14 | 1991 | 374 | |
| 15 | 1993 | 314 | |
| 16 | 2003 | 310 | |
| 17 | 2002 | 298 | |
| 18 | 1993 | 285 | |
| 19 | 1992 | 282 | |
| 20 | 1995 | 277 |
About Patrick M. Schlievert
Patrick M. Schlievert is a scholar working on Infectious Diseases, Immunology, Public Health, Environmental and Occupational Health, Molecular Biology and Epidemiology, having authored 406 papers that have together received 29.5k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (203 papers), Streptococcal Infections and Treatments (126 papers), Toxin Mechanisms and Immunotoxins (103 papers), Immune Response and Inflammation (59 papers), Clostridium difficile and Clostridium perfringens research (38 papers), Infective Endocarditis Diagnosis and Management (31 papers), Bacterial biofilms and quorum sensing (30 papers) and Monoclonal and Polyclonal Antibodies Research (24 papers). The work is most often cited by research in Infectious Diseases (16.0k citations), Clinical Biochemistry (2.8k citations), Microbiology (2.4k citations), Immunology (6.9k citations) and Public Health, Environmental and Occupational Health (8.6k citations). Patrick M. Schlievert has collaborated with scholars based in United States, Canada and Russia. Frequent co-authors include Paul M. Orwin, Martin M. Dinges, Jeremy M. Yarwood, Richard P. Novick, Barry N. Kreiswirth, John K. McCormick, Donald Y.M. Leung, Gregory A. Bohach, Marnie L. Peterson and Edward L. Kaplan. Their work appears in journals such as Infection and Immunity, The Journal of Infectious Diseases, Clinical Infectious Diseases, PLoS ONE and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.